1. Sharma A. Obesity and cardiovascular risk. Growth Hormone & IGF Res J. 2003; 13:7-10.
2. Yahai M, Samadanian F, Hosseini M, Azadbakht L. Prevalence of overweight, obesity and central obesity among
students of school of medicine in Isfahan university of medical sciences, Isfahan, Iran. J Health Syst Res. 2013; 9(4):421-
9. [In Persian]
3. Zhang H, Jiang L, Yang YJ, Ge RK, Zhou M, Hu H, et al. Aerobic exercise improves endothelial function and serum
adropin levels in obese adolescents independent of body weight loss. Sci Rep J. 2017; 7(1):1-8.
4. Motl RW, Arnett PA, Smith M, Barwick F, Ahlstrom B, Stover E. Worsening of symptoms is associated with lower
physical activity levels in individuals with multiple sclerosis. Mult Scler J. 2008; 14(1): 2-140.
5. Luo YN, Huang WZ, Liu XX, Markevych I, Bloom MS, Zhao T, et al. Greenspace with overweight and obesity: A
systematic review and meta‐analysis of epidemiological studies up to 2020. Obes Rev J. 2020; 21(11):e13078.
6. Janghorbani M AM, Willett WC, Gouya MM, Delavari A, Alikhani S, Mahdavi A. First nationwide survey of prevalence
of overweight, underweight, and abdominal obesity in Iranian adults. Obes Rev J. 2007; 15(11):2797-808.
7. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.
Jama. 2003; 290(7):932-40.
8. Victor SM MV, Francisco JR, Felix G, Joaguin M, Raimundo G. Elevated plasmahomocysteine levels in
hyperinsulinemic obese subjects. . J Nutr Biochem. 2002; 13.9-75.
9. Sharma S, Bakshi R, Tandon VR, Mahajan A. Postmenopausal obesity. Climacteric J. 2007; 10(1):19-24.
10. Braith RW, Stewart KJ. Resistance exercise training: its role in the prevention of cardiovascular disease. Circulation J.
2006; 113(22):2642-50.
11. Altena TS, Michaelson JL, Ball SD, Guilford BL, Thomas TR. Lipoprotein subfraction changes after continuous or
intermittent exercise training. Med Sci Sports Exerc.2006; 38(2):367-72.
12. DeFronzo R. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia
and atherosclerosis. Neth J Med. 1997; 50(5):191-7.
13. Aminot-Gilchrist DV, Anderson HD. Insulin resistance associated cardiovascular disease: potential benefits of
conjugated linoleic acid. AJCN .2011;79(6):1159-63
14. Marczuk N, Cecerska-Heryć E, Jesionowska A, Dołęgowska B. Adropin-physiological and pathophysiological role.
Advan in Hyg & Exper Med. 2016; 70.
15. Gao S, McMillan RP, Jacas J, Zhu Q, Li X, Kumar GK, et al. Regulation of substrate oxidation preferences in muscle by
the peptide hormone adropin. Diabetes. 2014; 63(10):3242-52.
16. Braith RW, Beck DT. Resistance exercise: training adaptations and developing a safe exercise prescription. Heart Fail
Rev. 2008; 13(1):69-79.
17. Aydin S, Kuloglu T, Aydin S, Eren MN, Yilmaz M, Kalayci M, et al. Expression of adropin in rat brain, cerebellum,
kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes. Mol Cell Biochem. 2013; 380(1):73-81.
18. Wong C-M, Wang Y, Lee JTH, Huang Z, Wu D, Xu A, et al. Adropin is a brain membrane-bound protein regulating
physical activity via the NB-3/Notch signaling pathway in mice. JBC. 2014; 289(37):25976-86.
19. Fujie S, Hasegawa N, Sato K, Fujita S, Sanada K, Hamaoka T, et al. Aerobic exercise training-induced changes in serum
adropin level are associated with reduced arterial stiffness in middle-aged and older adults. Am J Physiol Heart Circ.
2015; 309(10):H1642-H7.
20. Gibala MJ, Little JP, MacDonald MJ, Hawley JA. Physiological adaptations to low‐volume, high‐intensity interval
training in health and disease. Physiol J. 2012; 590(5):1077-84.
21. Lazzer S, Tringali G, Caccavale M, De Micheli R, Abbruzzese L, Sartorio A. Effects of high-intensity interval training
on physical capacities and substrate oxidation rate in obese adolescents. J Endocrinol Inves. 2017; 40(2):217-26.
22. Czarkowska-Paczek B, Bartlomiejczyk I, Gabrys T, Przybylski J, Nowak M, Paczek L. Lack of relationship between
interleukin-6 and CRP levels in healthy male athletes. Mol Immunol J. 2005; 99(1):136-40.
23. Bermingham MA, Mahajan D, Neaverson MA. Blood lipids of cardiac patients after acute exercise on land and in water.
Arc Phys M. 2004; 85(3):509-11.
24. Theodorou AA, Panayiotou G, Volaklis KA, Douda HT, Paschalis V, Nikolaidis MG, et al. Aerobic, resistance and
combined training and detraining on body composition, muscle strength, lipid profile and inflammation in coronary artery
disease patients. Res Sports Med. 2016; 24(3):171-84.
25. Qu H-Q, Li Q, Rentfro AR, Fisher-Hoch SP, McCormick JB. The definition of insulin resistance using HOMA-IR for
Americans of Mexican descent using machine learning. PloS one. 2011;6(6): 21041.
26. Baker J, Davies B. High intensity exercise assessment: relationships between laboratory and field measures of
performance. JSAMS. 2002; 5(4):341-7.
27. Burgomaster KA, Hughes SC, Heigenhauser GJ, Bradwell SN, Gibala MJ. Six sessions of sprint interval training
increases muscle oxidative potential and cycle endurance capacity in humans. J Appl Physiol. 2005; 98(6):1985-90.
28. Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta M, et al. Adropin is a novel regulator of endothelial function .
Circulation. 2010; 122(11): 185-92.
29. Ganesh‐Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH, et al. Adropin deficiency is associated with
increased adiposity and insulin resistance. Obes. 2012; 20(7):1394-402.
30. Butler AA, Tam CS, Stanhope KL, Wolfe BM, Ali MR, O'Keeffe M, et al. Low circulating adropin concentrations with
obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J
Clin Endocr. 2012; 97(10):3783-91.
31. GAO S, McMillan RP, Zhu Q, Lopaschuk GD, Hulver MW, Butler AA. Therapeutic effects of adropin on glucose
tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Mol Metab.2015; (4)4: 310-24.
32. Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, et al. Identification of adropin as a secreted
factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab metabolism. 2008;
8(6):46.8-81.
33. Wu L, Fang J, Chen L, Zhao Z, Luo Y, Lin C, et al. Low serum adropin is associated with coronary atherosclerosis in
type 2 diabetic and non-diabetic patients. CCLM.2014; 52(5):751-8.
34. Nouri H, Ghofrani M. The effect of eight weeks of practice High intensity interval (HIT) and Moderate-Intensity
Continuous Training (MICT) on Adropin, Nitric Oxide (NO) and Blood pressure in obese boys. Educ Sci Borders. 2018;
3(10):43-65. [In Persian]
35. Soori R, Ramezankhani A, Ravasi AA, Akbarnejad A. Effect of aerobic exercise and caloric restriction on serum adropin
levels and homa-ir in obese sedentary women. Int Sports Physiol. 2017; 9(34):49-62. [In Persian]
36. Little JP, Gillen JB, Percival ME, Safdar A, Tarnopolsky MA, Punthakee Z, et al. Low-volume high-intensity interval
training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes. J Appl
Phyiol.2011; 111(6):1554-60.
37. Kraemer R, Durand R, Hollander D, Tryniecki J, Hebert E, Castracane V. Ghrelin and other glucoregulatory hormone
responses to eccentric and concentric muscle contractions. Endocrine. 2004; 24(1):93-8.
38. Ghanbari-Niaki A. Ghrelin and glucoregulatory hormone responses to a single circuit resistance exercise in male college
students. Clin Biochem. 2006; 39(10):966-70. [In Persian]
39. Kang J, Robertson RJ, Hagberg JM, Kelley DE, Goss FL, Dasilva SG, et al. Effect of exercise intensity on glucose and
insulin metabolism in obese individuals and obese NIDDM patients. Diabetes care. 1996; 19(4):341-9.
40. Seals DR, Hagberg JM, Hurley BF, Ehsani AA, Holloszy JO. Effects of endurance training on glucose tolerance and
plasma lipid levels in older men and women. Jama. 1984; 252(5):645-9.
41. Assarzade Noushabadi M, Abedi B. Effects of combination training on insulin resistance index and some inflammatory
markers in inactive men. Horizon Med Sci. 2012; 18(3):95-105. [In Persian]
42. Henriksen EJ. Invited review: Effects of acute exercise and exercise training on insulin resistance. J Appl Phyiol. 2002;
93(2):788-96.
43. Wagenmakers AJ, Bonen A, Dohm GL, van Loon LJ. Lipid metabolism, exercise and insulin action. Essays biochem.
2006; 42:47-59.
44. Tjønna AE, Lee SJ, Rognmo Ø, Stølen TO, Bye A, Haram PM, et al. Aerobic interval training versus continuous
moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. 2008; 118(4):346-54.
45. Suri R HRS, Wahhabi K, Shab Khiz F .The effect of periodic aerobic exercise on serum RBP4 and insulin resistance
index in type 2 diabetic patients. J Diabets Metab Disord. 2011; 10(4):388-97.
46. Tahmasebi V HF, Arefirad T, GHorbani M. Response of inflammatory markers and insulin resistance to a session of
circular resistance activity in healthy men. Iran J Diabetes Lipid Disord. 2012; 11(5):455-63. [In Persian]
47. Nikseresht M, Agha-Alinejad H, Azarbayjani MA, Ebrahim K. Effects of nonlinear resistance and aerobic interval
training on cytokines and insulin resistance in sedentary men who are obese. J Strength Cond Res.2014; 28(9):2560-8.
[In Persian]
48. Ahmadizad S, Haghighi AH, Hamedinia MR. Effects of resistance versus endurance training on serum adiponectin and
insulin resistance index. Eur J Endocrinol. 2007; 157(5):625-32. [In Persian]
49. Andersson A, Sjö din A, Olsson R, Vessby B. Effects of physical exercise on phospholipid fatty acid composition in
skeletal muscle. Am J Physiol Endocrinol. 1998; 274(3): 432-8.
50. Fenicchia L, Kanaley J, Azevedo Jr J, Miller C, Weinstock R, Carhart R, et al. Influence of resistance exercise training on
glucose control in women with type 2 diabetes. Metabolism. 2004; 53(3):284-9.
51. Suh S, Jeong I-K, Kim MY, Kim YS, Shin S, Kim SS, et al. Effects of resistance training and aerobic exercise on insulin
sensitivity in overweight Korean adolescents: a controlled randomized trial. Diabetes Metab J. 2011; 35(4):418-26.
52. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension,
dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes care. 1991; 14(3):173-94.